Name: Applications for Food and Drug Administration Approval to Market New Drug - Revision of Postmarketing Reporting Requirements (US Food and Drug Adminis (en Inglés)
Price: 17.56 USD
Availability: InStock
Author: The Law Library
ISBN: 9781727250930

portada Applications for Food and Drug Administration Approval to Market New Drug - Revision of Postmarketing Reporting Requirements (US Food and Drug Adminis (en Inglés)

Applications for Food and Drug Administration Approval to Market New Drug - Revision of Postmarketing Reporting Requirements (US Food and Drug Adminis (en Inglés)

Formato

Libro Físico

Autor

The Law Library

Editorial

Createspace

Idioma

Inglés

N° páginas

Encuadernación

Tapa Blanda

Dimensiones

25.4 x 17.8 x 0.2 cm

Peso

0.08 kg.

ISBN13

9781727250930

Categorías

Teoría general del derecho

Applications for Food and Drug Administration Approval to Market New Drug - Revision of Postmarketing Reporting Requirements (US Food and Drug Adminis (en Inglés)

The Law Library (Autor) · Createspace · Tapa Blanda

Libro Nuevo Origen: Estados Unidos

Envío: 8 a 10 días háb.

$ 19.90$ 17.56

-12%

Libro Nuevo

Quedan más de 100 unidades

$ 17.56

Llega entre el 28 Jul y el 03 Ago a FL. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Applications for Food and Drug Administration Approval to Market New Drug - Revision of Postmarketing Reporting Requirements (US Food and Drug Adminis (en Inglés)"

Applications for Food and Drug Administration Approval to Market New Drug - Revision of Postmarketing Reporting Requirements (US Food and Drug Administration Regulation) (FDA) (2018 Edition) The Law Library presents the complete text of the Applications for Food and Drug Administration Approval to Market New Drug - Revision of Postmarketing Reporting Requirements (US Food and Drug Administration Regulation) (FDA) (2018 Edition). Updated as of May 29, 2018 The Food and Drug Administration (FDA or the Agency) is issuing an interim final rule amending its postmarketing reporting regulations implementing certain provisions of the Federal Food, Drug and Cosmetic Act. The provisions of the Federal Food, Drug and Cosmetic Act require manufacturers who are the sole manufacturers of certain drug products to notify FDA at least 6 months before discontinuance of manufacture of the products. This interim final rule modifies the term "discontinuance" and clarifies the term "sole manufacturer" with respect to notification of discontinuance requirements. The broader reporting resulting from these changes will enable FDA to improve its collection and distribution of drug shortage information to physician and patient organizations and to work with manufacturers and other stakeholders to respond to potential drug shortages. This book contains: - The complete text of the Applications for Food and Drug Administration Approval to Market New Drug - Revision of Postmarketing Reporting Requirements (US Food and Drug Administration Regulation) (FDA) (2018 Edition) - A table of contents with the page number of each section

Opiniones del libro

¿Leíste este libro? Inicia sesión para poder agregar tu propia evaluación.

Ver más opiniones de clientes

0% (0)
0% (0)
0% (0)
0% (0)
0% (0)

Preguntas y respuestas sobre el libro

¿Tienes una pregunta sobre el libro? Inicia sesión para poder agregar tu propia pregunta.

Opiniones sobre Buscalibre

Ver más opiniones de clientes

Applications for Food and Drug Administration Approval to Market New Drug - Revision of Postmarketing Reporting Requirements (US Food and Drug Adminis (en Inglés) - The Law Library

Reseña del libro "Applications for Food and Drug Administration Approval to Market New Drug - Revision of Postmarketing Reporting Requirements (US Food and Drug Adminis (en Inglés)"

Opiniones del libro

Preguntas frecuentes sobre el libro

¿El libro es original?

¿En qué Idioma está escrito el libro?

¿Cuál es la encuadernación de este libro?

Preguntas y respuestas sobre el libro

Opiniones sobre Buscalibre